RESUMO
Mucormycosis, also known as zygomycosis, is an aggressive infection caused by a ubiquitous group of molds known as mucormycetes and is often associated with immune suppression or trauma among immunocompetent populations. We present the case of a 19-year-old woman who was involved in a motor vehicle accident in whom rapidly progressive invasive cutaneous facial mucormycosis subsequently developed. The diagnosis, treatment options, and incidence of this disease process are discussed in the context of trauma.
Assuntos
Traumatismos Faciais/microbiologia , Mucormicose/diagnóstico , Acidentes de Trânsito , Anfotericina B/uso terapêutico , Antifúngicos/uso terapêutico , Biomarcadores/análise , Terapia Combinada , Diagnóstico Diferencial , Traumatismos Faciais/tratamento farmacológico , Traumatismos Faciais/cirurgia , Evolução Fatal , Feminino , Humanos , Mucormicose/tratamento farmacológico , Mucormicose/cirurgia , Adulto JovemRESUMO
UNLABELLED: Despite significant advances in surgical procedures and treatment, long-term prognosis for patients with oral cancer remains poor, with survival rates among the lowest of major cancers. Better methods are desperately needed to identify potential malignancies early when treatments are more effective. OBJECTIVE: To develop robust classification models from cytology-on-a-chip measurements that mirror diagnostic performance of gold standard approach involving tissue biopsy. MATERIALS AND METHODS: Measurements were recorded from 714 prospectively recruited patients with suspicious lesions across 6 diagnostic categories (each confirmed by tissue biopsy -histopathology) using a powerful new 'cytology-on-a-chip' approach capable of executing high content analysis at a single cell level. Over 200 cellular features related to biomarker expression, nuclear parameters and cellular morphology were recorded per cell. By cataloging an average of 2000 cells per patient, these efforts resulted in nearly 13 million indexed objects. RESULTS: Binary "low-risk"/"high-risk" models yielded AUC values of 0.88 and 0.84 for training and validation models, respectively, with an accompanying difference in sensitivity+specificity of 6.2%. In terms of accuracy, this model accurately predicted the correct diagnosis approximately 70% of the time, compared to the 69% initial agreement rate of the pool of expert pathologists. Key parameters identified in these models included cell circularity, Ki67 and EGFR expression, nuclear-cytoplasmic ratio, nuclear area, and cell area. CONCLUSIONS: This chip-based approach yields objective data that can be leveraged for diagnosis and management of patients with PMOL as well as uncovering new molecular-level insights behind cytological differences across the OED spectrum.
Assuntos
Dispositivos Lab-On-A-Chip , Monitorização Fisiológica/métodos , Neoplasias Bucais/patologia , Automação , Biópsia/métodos , Feminino , Humanos , Masculino , Estudos ProspectivosRESUMO
A 13-year-old female, who had been experiencing episodes of mandibular pain and swelling for approximately six months, was referred to a university urgent care dental clinic for evaluation after receiving endodontic treatment. At the referral examination, clinical and radiographic findings were suggestive of osteomyelitis. The purpose of this report is to present the possible etiology, clinical and radiographic findings and surgical management of mandibular osteomyelitis in an adolescent patient.
Assuntos
Doenças Mandibulares/diagnóstico , Osteomielite/diagnóstico , Adolescente , Diagnóstico Diferencial , Feminino , Humanos , Doenças Mandibulares/cirurgia , Osteomielite/cirurgiaRESUMO
OBJECTIVE: Interobserver agreement in the context of oral epithelial dysplasia (OED) grading has been notoriously unreliable and can impose barriers for developing new molecular markers and diagnostic technologies. This paper aimed to report the details of a 3-stage histopathology review and adjudication process with the goal of achieving a consensus histopathologic diagnosis of each biopsy. STUDY DESIGN: Two adjacent serial histologic sections of oral lesions from 846 patients were independently scored by 2 different pathologists from a pool of 4. In instances where the original 2 pathologists disagreed, a third, independent adjudicating pathologist conducted a review of both sections. If a majority agreement was not achieved, the third stage involved a face-to-face consensus review. RESULTS: Individual pathologist pair κ values ranged from 0.251 to 0.706 (fair-good) before the 3-stage review process. During the initial review phase, the 2 pathologists agreed on a diagnosis for 69.9% of the cases. After the adjudication review by a third pathologist, an additional 22.8% of cases were given a consensus diagnosis (agreement of 2 out of 3 pathologists). After the face-to-face review, the remaining 7.3% of cases had a consensus diagnosis. CONCLUSIONS: The use of the defined protocol resulted in a substantial increase (30%) in diagnostic agreement and has the potential to improve the level of agreement for establishing gold standards for studies based on histopathologic diagnosis.
Assuntos
Neoplasias Bucais/patologia , Patologia Clínica/métodos , Biópsia , Carcinoma in Situ/patologia , Transformação Celular Neoplásica/patologia , Ensaios Clínicos como Assunto , Humanos , Mucosa Bucal/patologia , Variações Dependentes do Observador , Lesões Pré-Cancerosas/patologiaRESUMO
Magnetic resonance imaging (MRI) is the modality of choice to identify intracranial or perineural spread from a head and neck primary tumor. Perineural spread is a form of metastatic disease in which primary tumors spread along neural pathways. Orbital cellulitis is a sight-threatening, and potentially life-threatening condition. Urgent imaging is performed to assess the anatomic extent of disease, including postseptal, cavernous sinus, and intracranial involvement, and identify orbital abscesses that require exploration and drainage. MRI is useful in the evaluation of the brachial plexus.
Assuntos
Neuropatias do Plexo Braquial/diagnóstico , Neoplasias de Cabeça e Pescoço/diagnóstico , Imageamento por Ressonância Magnética/métodos , Celulite Orbitária/diagnóstico , Meios de Contraste , HumanosRESUMO
Oral health care in patients undergoing chemotherapy and/or radiation therapy can be complex. Care delivered by a multidisciplinary approach is timely and streamlines the allocation of resources to provide prompt care and to attain favorable outcomes. A hospital dentist, oral and maxillofacial surgeon, and a maxillofacial prosthodontist must be involved early to prevent avoidable oral complications. Prevention and thorough preparation are vital before the start of chemotherapy and radiation therapy. Oral complications must be addressed immediately and, even with the best management, can cause delays and interruption in treatment, with serious consequences for the outcome and prognosis.